ARCHIVES

New Treatment For Malignant Glioma, IL13-PE38, Tested In Early Clinical Trials

This article is from The Cancer Letter archive.

Vol. 24 No. 12 | December 28, 2001

Download PDF Visit The Full Archive

Related Articles

Phase III Study: Lymphoseek Superior to Vital Blue Dye

June 24, 2011

NCCS Networker Volume 2 Issue 4, Fall 1988

September 13, 1988

Study Suggests Surveillance Colonoscopies Overperformed

August 27, 2004

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

Ohio State Breaks Ground For $1 Billion Expansion Of Medical Center, Cancer Hospital

June 18, 2010

In Brief Yale Cancer Center Begins Reorganization, Names New Deputy Director, Prevention Chief

January 6, 1995